Kaiser Fontana Medical Center is a large Kaiser Permanente medical facility and 420-bed hospital in Fontana, California. Built in 1955 to replace the smaller hospital at the Kaiser Steel Mill, the facility now serves over 400,000 members of Kaiser Permanente's health care plans in the area.

There are 420 beds in Kaiser Permanente - Fontana.

During the past decade, Kaiser Permanente - Fontana conducted 94 clinical trials. In the 10-year time frame, 94 clinical trials started and 50 clinical trials were completed, i.e. on average, 53.2% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 31 clinical trials were completed. i.e. 134.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente - Fontana" #1 sponsor was "National Cancer Institute (NCI)" with 64 trials, followed by "SWOG Cancer Research Network" with 31 trials sponsored, "NSABP Foundation Inc" with 7 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente - Fontana" #1 collaborator was "National Cancer Institute (NCI)" with 56 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator and "Astellas Pharma US, Inc." with 2 trials as a collaborator. Other collaborators include 32 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente - Fontana" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Lung Cancer AJCC v8" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Breast Cancer" (7 trials) and "Stage IVA Lung Cancer AJCC v8" (7 trials). Many other conditions were trialed in "Kaiser Permanente - Fontana" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente - Fontana" are "Drug" (105 trials), "Other" (85 trials), "Biological" (61 trials), "Procedure" (30 trials) and "Radiation" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (45 trials), "Quality-of-Life Assessment" (27 trials), "Biospecimen Collection" (19 trials), "Computed Tomography" (19 trials) and "Nivolumab" (19 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente - Fontana" are 122 trials for "All" genders, 18 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Kaiser Permanente - Fontana". 1 are not yet recruiting, 30 are recruiting, 65 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Kaiser Permanente - Fontana, 4 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente - Fontana, 0 "Phase 1" clinical trials were conducted, 59 "Phase 2" clinical trials and 75 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".